Cognetivity Neurosciences Ltd. operates as a technology company. The firm engages in the development of platforms for medical uses such as early detection and monitoring of cognitive impairment in neurodegenerative diseases. It uses visual stimulus based diagnostic test and artificial intelligence tools, such as Integrated Cognitive Assessment. The company was founded by Sina Habibi and Seyed-Mahdi Khaligh-Razavi on December 11, 2015 and is headquartered in Vancouver, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company